Cel-Sci Amex CVM ex HIV Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Amex CVM ex HIV

CVM 5.440

-7.2%

Jan 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Toni Wheeler who wrote (5)	2/13/2000 11:48:00 PM
From: fmrick	Read Replies (1) of 25

Found you guys over here! Yahoo! is getting a little crazy. But with the run last week, who's to blame them. Looks like we will see an interesting week. We should see a release or two, along with whatever Geert is up to on the Conference front. I expect something from one of the Multikine studies. I don't expect the publication news yet. I look for that later. As for this being premature, I don't think so. If they are right about the results what is this worth? Multikine alone is worth, say, $200/share. So if you figure 4 years to get there, what would a share be worth today? If you want 100% gain per year it would be worth $12.50. If you will settle for 50%/yr it should sell for about $40 today. I used 4 years, what if it only takes 2 or 3? And what about LEAPS and HGP-30? Or European and Canadian sales, not requiring FDA approval. No, this should be valued much higher, if the science is what they claim. Let's see the results. I've added a link to the old HIV board to direct people over here. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next